Cargando…

Selective Progesterone Receptor Modulators—Mechanisms and Therapeutic Utility

Selective progesterone receptor modulators (SPRMs) are a new class of compounds developed to target the progesterone receptor (PR) with a mix of agonist and antagonist properties. These compounds have been introduced for the treatment of several gynecological conditions based on the critical role of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Islam, Md Soriful, Afrin, Sadia, Jones, Sara Isabel, Segars, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659360/ https://www.ncbi.nlm.nih.gov/pubmed/32365199 http://dx.doi.org/10.1210/endrev/bnaa012

Ejemplares similares

Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids
por: Islam, Md Soriful, et al.
Publicado: (2021)

Green Tea in Reproductive Cancers: Could Treatment Be as Simple?
por: Parish, Maclaine, et al.
Publicado: (2023)

Targeting fibrotic signaling pathways by EGCG as a therapeutic strategy for uterine fibroids
por: Islam, Md Soriful, et al.
Publicado: (2023)

Green Tea and Benign Gynecologic Disorders: A New Trick for An Old Beverage?
por: Hazimeh, Dana, et al.
Publicado: (2023)

90 YEARS OF PROGESTERONE: Selective progesterone receptor modulators in gynaecological therapies
por: Critchley, H O D, et al.
Publicado: (2020)

Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies
por: Wagenfeld, Andrea, et al.
Publicado: (2016)

Molecular Modeling on Structure-Function Analysis of Human Progesterone Receptor Modulators
por: Pal, Ria, et al.
Publicado: (2011)

Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids(†)
por: Ali, Mohamed, et al.
Publicado: (2017)

Natural Products and Disease Prevention, Relief and Treatment
por: Islam, Md Soriful
Publicado: (2022)

Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive Overview
por: Schultze-Mosgau, Marcus-Hillert, et al.
Publicado: (2021)

Role of nonhuman primate models in the discovery and clinical development of selective progesterone receptor modulators (SPRMs)
por: Chwalisz, Kristof, et al.
Publicado: (2006)

90 YEARS OF PROGESTERONE: Molecular mechanisms of progesterone receptor action on the breast cancer genome
por: Beato, Miguel, et al.
Publicado: (2020)

Progesterone receptor isoforms A and B: new insights into the mechanism of progesterone resistance for the treatment of endometrial carcinoma
por: Shao, Ruijin
Publicado: (2013)

New Selective Progesterone Receptor Modulators and Their Impact on the RANK/RANKL Complex Activity
por: Błaszczak-Świątkiewicz, Katarzyna
Publicado: (2020)

Ulipristal acetate, a progesterone receptor modulator for emergency contraception
por: Jadav, Shilpa P., et al.
Publicado: (2012)

Markers of Cellular Proliferation, Apoptosis, Estrogen/Progesterone Receptor Expression and Fibrosis in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids
por: Szydłowska, Iwona, et al.
Publicado: (2021)

Progesterone Signaling and Uterine Fibroid Pathogenesis; Molecular Mechanisms and Potential Therapeutics
por: Ali, Mohamed, et al.
Publicado: (2023)

SUN-019 The Selective Progesterone Receptor Modulator Ulipristal Acetate Blocks Glucocorticoid Receptor Transactivation
por: Smalls, Benjamin, et al.
Publicado: (2019)

Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure
por: Reis, Fernando M, et al.
Publicado: (2020)

Progesterone receptors - animal models and cell signaling in breast cancer: Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells
por: Graham, J Dinny, et al.
Publicado: (2002)

Progesterone effects on the oligodendrocyte linage: all roads lead to the progesterone receptor
por: Jure, Ignacio, et al.
Publicado: (2019)

Effect of a Selective Progesterone Receptor Modulator on Induction of Apoptosis in Uterine Fibroids In Vivo
por: Horak, Petr, et al.
Publicado: (2012)

Effect of the Novel Selective Progesterone Receptor Modulator Vilaprisan on Ovarian Activity in Healthy Women
por: Schütt, Barbara, et al.
Publicado: (2017)

Pharmacokinetics and Safety of the Novel Selective Progesterone Receptor Modulator Vilaprisan in Participants With Renal Impairment
por: Schultze‐Mosgau, Marcus‐Hillert, et al.
Publicado: (2020)

Pharmacokinetics and Safety of the Selective Progesterone Receptor Modulator Vilaprisan in Chinese Healthy Postmenopausal Women
por: Liu, Hongzhong, et al.
Publicado: (2020)

Rural women participation in farm and off-farm activities and household income in Bangladesh
por: Islam, Md. Soriful, et al.
Publicado: (2022)

Selective estrogen receptor modulators: tissue specificity and clinical utility
por: Martinkovich, Stephen, et al.
Publicado: (2014)

Natural flavonols: actions, mechanisms, and potential therapeutic utility for various diseases
por: Mahmud, Aar Rafi, et al.
Publicado: (2023)

Progesterone receptor modulates estrogen receptor-α action in breast cancer
por: Mohammed, Hisham, et al.
Publicado: (2015)

SARS-CoV-2 infection and diabetes: Pathophysiological mechanism of multi-system organ failure
por: Roy, Bipradas, et al.
Publicado: (2022)

Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate
por: Rabe, Thomas, et al.
Publicado: (2018)

Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium
por: Whitaker, L.H.R., et al.
Publicado: (2017)

The Role of Progesterone Receptors in Breast Cancer
por: Li, Zhuo, et al.
Publicado: (2022)

The Therapeutic Uses of Progesterone
por: Paterson, Susanne J.
Publicado: (1939)

Progesterone receptors in normal mammary gland: receptor modulations in relation to differentiation
Publicado: (1980)

Progesterone receptors - animal models and cell signaling in breast cancer: Role of steroid receptor coactivators and corepressors of progesterone receptors in breast cancer
por: Gao, Xiuhua, et al.
Publicado: (2002)

Creative social media use for Covid-19 prevention in Bangladesh: a structural equation modeling approach
por: Islam, Md. Monirul, et al.
Publicado: (2021)

Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”
por: Rabe, Thomas, et al.
Publicado: (2018)

Predictive Factors of Response to Selective Progesterone Receptor Modulator (Ulipristal Acetate) in the Pharmacological Treatment of Uterine Fibroids
por: Szydłowska, Iwona, et al.
Publicado: (2020)

Markers of Inflammation and Vascular Parameters in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids
por: Szydłowska, Iwona, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nts456frvv6sl7so5m8jf4dhji